Arena Pharmaceuticals, Inc. Debt Instrument, Fair Value Disclosure
Arena Pharmaceuticals, Inc. had Debt Instrument, Fair Value Disclosure of $47.90 million as of 2009-07-31, per its 10-Q filed 2012-08-09.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFairValue · last filed 2012-08-09
- 2009-07-31: Debt Instrument, Fair Value Disclosure $47.90M.
| Period end | Debt Instrument, Fair Value Disclosure |
|---|---|
| 2009-07-31 | $47.90M 10-Q · filed 2012-08-09 |